Literature DB >> 20200594

Role of CTLA-4, IL-18 and IL-10 on the Induction of Low Dose Oral Tolerance.

Kathleen Siobhan Barone1, Rachael Burns, Stephanie Horton, Armando Retana, Lindsey Jackson Meredith Wall, Tifany Nolan.   

Abstract

Oral Tolerance is the temporary loss of systemic immunological responsiveness to a specific soluble antigen after ingestion of that antigen. Results from our lab and others indicated that CTLA-4 and lack of IL-12 played a role in the induction of low dose oral tolerance at the Th1 cell level. Previous literature suggested that IL-18 also played a role in preventing oral tolerance induction while the cytokine IL-10 had been shown to be a factor contributing to suppressed immune responses. To determine the role of CTLA-4 in conjunction with either IL-18 or IL-10 in low dose oral tolerance induction, anti-CTLA-4 mAb and either IL-18 or anti-IL-10 mAb were administered concurrently to mice fed either ovalbumin (OVA) or water. Results showed that the PLN cell proliferation of mice treated with anti-CTLA-4 mAb and IL-18 remained significantly suppressed compared with water-fed controls, while a partial abrogation of suppressed IL-4 and IFN-gamma levels were observed. In contrast, mice treated with anti-CTLA-4 mAb and anti-IL-10 mAb exhibited a reversal of PLN cell proliferation and IL-4 suppression; however, IFN-gamma levels remained suppressed. Results suggest that IL-10, IL-18 and CTLA-4 play roles in the induction of oral tolerance at the cell proliferation and cytokine level.

Entities:  

Year:  2008        PMID: 20200594      PMCID: PMC2830657          DOI: 10.3101/1098-7096(2008)69[11:ROCIAI]2.0.CO;2

Source DB:  PubMed          Journal:  J Ky Acad Sci        ISSN: 1098-7096


  39 in total

1.  The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit.

Authors:  J T Chang; B M Segal; K Nakanishi; H Okamura; E M Shevach
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

2.  Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells.

Authors:  K Matsui; T Yoshimoto; H Tsutsui; Y Hyodo; N Hayashi; K Hiroishi; N Kawada; H Okamura; K Nakanishi; K Higashino
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

3.  Inductive events in oral tolerance in the TCR transgenic adoptive transfer model.

Authors:  Y Chen; J Inobe; H L Weiner
Journal:  Cell Immunol       Date:  1997-05-25       Impact factor: 4.868

4.  Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites.

Authors:  Damien Chaussabel; Roshanak Tolouei Semnani; Mary Ann McDowell; David Sacks; Alan Sher; Thomas B Nutman
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

5.  CTLA-4 is required for the induction of high dose oral tolerance.

Authors:  E B Samoilova; J L Horton; H Zhang; S J Khoury; H L Weiner; Y Chen
Journal:  Int Immunol       Date:  1998-04       Impact factor: 4.823

6.  Role of interleukin 12 and costimulators in T cell anergy in vivo.

Authors:  L Van Parijs; V L Perez; A Biuckians; R G Maki; C A London; A K Abbas
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

7.  Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines.

Authors:  W J Karpus; K J Kennedy; S L Kunkel; N W Lukacs
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

8.  CTLA-4 ligation blocks CD28-dependent T cell activation.

Authors:  T L Walunas; C Y Bakker; J A Bluestone
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

9.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.

Authors:  M D Sadick; F P Heinzel; B J Holaday; R T Pu; R S Dawkins; R M Locksley
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

10.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Authors:  M F Krummel; J P Allison
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.